Frequency of abnormal carbohydrate metabolism and diabetes in a population-based screening of adolescents.

PubWeight™: 3.23‹?› | Rank: Top 1%

🔗 View Article (PMID 15973311)

Published in J Pediatr on June 01, 2005

Authors

Lawrence M Dolan1, Judy Bean, David D'Alessio, Robert M Cohen, John A Morrison, Elizabeth Goodman, Stephen R Daniels

Author Affiliations

1: Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA. Larry.Dolan@chmcc.org

Articles citing this

Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA (2014) 4.83

Prevalence of pre-diabetes and its association with clustering of cardiometabolic risk factors and hyperinsulinemia among U.S. adolescents: National Health and Nutrition Examination Survey 2005-2006. Diabetes Care (2008) 2.73

Instability in the diagnosis of metabolic syndrome in adolescents. Circulation (2007) 2.29

Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood. JAMA (2017) 2.22

Presence of diabetes risk factors in a large U.S. eighth-grade cohort. Diabetes Care (2006) 2.10

Diagnosis of diabetes using hemoglobin A1c: should recommendations in adults be extrapolated to adolescents? J Pediatr (2010) 1.45

Risk factors for type 2 diabetes in a sixth- grade multiracial cohort: the HEALTHY study. Diabetes Care (2009) 1.44

Socioeconomic status gradients in inflammation in adolescence. Psychosom Med (2013) 1.15

Evaluation of nonfasting tests to screen for childhood and adolescent dysglycemia. Diabetes Care (2011) 1.14

The relationships of adiponectin with insulin and lipids are strengthened with increasing adiposity. J Clin Endocrinol Metab (2005) 1.13

A prospective study of psychological distress and weight status in adolescents/young adults. Ann Behav Med (2012) 1.06

Prevalence of cardiometabolic risk factors by weight status in a population-based sample of Quebec children and adolescents. Can J Cardiol (2008) 0.99

Low Social Status Markers: Do They Predict Depressive Symptoms in Adolescence? Race Soc Probl (2011) 0.91

Pubarche as well as thelarche may be a marker for the onset of puberty. J Pediatr Adolesc Gynecol (2008) 0.87

Hemoglobin A1c assay variations and implications for diabetes screening in obese youth. Pediatr Diabetes (2014) 0.85

Cost-effectiveness of screening strategies for identifying pediatric diabetes mellitus and dysglycemia. JAMA Pediatr (2013) 0.85

Metabolic syndrome. Pediatr Rev (2012) 0.84

Re: "Prevalence of diagnosed and undiagnosed type 2 diabetes mellitus among US adolescents: results from the continuous NHANES, 1999-2010". Am J Epidemiol (2013) 0.84

Breastfeeding helps explain racial and socioeconomic status disparities in adolescent adiposity. Pediatrics (2008) 0.83

Optimism and the socioeconomic status gradient in adolescent adiposity. J Adolesc Health (2011) 0.82

Impact of obesity on metabolic syndrome among adolescents as compared with adults in Korea. Yonsei Med J (2011) 0.81

Insulin Sensitivity and β-Cell Function Improve after Gastric Bypass in Severely Obese Adolescents. J Pediatr (2015) 0.81

Gender differences in the relationships among obesity, adiponectin and brachial artery distensibility in adolescents and young adults. Int J Obes (Lond) (2009) 0.79

Requested meals versus scheduled meals. Int J Gen Med (2012) 0.79

Novel variations in the adiponectin gene (ADIPOQ) may affect distribution of oligomeric complexes. Springerplus (2012) 0.78

Hostility and adiposity mediate disparities in insulin resistance among adolescents and young adults. J Pediatr (2010) 0.78

An 8-Year Prospective Study of Depressive Symptoms and Change in Insulin From Adolescence to Young Adulthood. Psychosom Med (2015) 0.77

The role of perceived discrimination during childhood and adolescence in understanding racial and socioeconomic influences on depression in young adulthood. J Pediatr (2014) 0.77

Association of optimism with cardiometabolic risk in adolescents. J Adolesc Health (2012) 0.77

Rapid deterioration of insulin secretion in obese adolescents preceding the onset of type 2 diabetes. J Pediatr (2014) 0.77

Medical and non-medical complications among children and adolescents with excessive body weight. BMC Pediatr (2014) 0.77

Screening for abnormalities of carbohydrate metabolism in teens. J Pediatr (2005) 0.77

Association of INSIG2 polymorphism with overweight and LDL in children. PLoS One (2015) 0.76

A risk score for identifying overweight adolescents with dysglycemia in primary care settings. J Pediatr Endocrinol Metab (2013) 0.75

Fasting glucose is not useful in identifying obese white children with impaired glucose tolerance. J Pediatr (2006) 0.75

Challenges in modelling the random structure correctly in growth mixture models and the impact this has on model mixtures. J Dev Orig Health Dis (2014) 0.75

The typology of metabolic syndrome in the transition to adulthood. J Clin Endocrinol Metab (2014) 0.75

Articles by these authors

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74

Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet (2005) 13.77

Evidence based physical activity for school-age youth. J Pediatr (2005) 13.50

Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med (2008) 9.64

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet (2010) 9.20

AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation (2002) 9.04

Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med (2011) 7.16

Decline in physical activity in black girls and white girls during adolescence. N Engl J Med (2002) 7.06

Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation (2005) 7.04

Lipid screening and cardiovascular health in childhood. Pediatrics (2008) 6.62

Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension (2006) 5.59

Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics (2004) 5.01

Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab (2006) 4.98

Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol (2007) 4.78

Relation between the changes in physical activity and body-mass index during adolescence: a multicentre longitudinal study. Lancet (2005) 4.65

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA (2003) 4.16

Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care (2010) 4.10

Guidelines for lipid screening in children and adolescents: bringing evidence to the debate. Pediatrics (2012) 3.98

A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab (2003) 3.93

Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation (2007) 3.90

Physical activity intervention studies: what we know and what we need to know: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity); Council on Cardiovascular Disease in the Young; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research. Circulation (2006) 3.72

Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation (2009) 3.59

Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab (2004) 3.54

Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation (2003) 3.33

Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension (2009) 3.22

Correlates of beverage intake in adolescent girls: the National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr (2006) 3.15

Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation (2006) 3.00

Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev (2006) 2.99

Cardiovascular health in childhood: A statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation (2002) 2.96

Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association. Circulation (2012) 2.95

Racial differences in the relation between uncoupling protein genes and resting energy expenditure. Am J Clin Nutr (2002) 2.84

A controlled high-fat diet induces an obese syndrome in rats. J Nutr (2003) 2.80

Severe obesity in children and adolescents: identification, associated health risks, and treatment approaches: a scientific statement from the American Heart Association. Circulation (2013) 2.71

American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation (2003) 2.51

American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation (2003) 2.49

Parental report of outdoor playtime as a measure of physical activity in preschool-aged children. Arch Pediatr Adolesc Med (2004) 2.41

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol (2006) 2.41

Influence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study, the Childhood Determinants of Adult Health Study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium. Circulation (2010) 2.39

Effect of blinded peer review on abstract acceptance. JAMA (2006) 2.38

Effects of sibutramine treatment in obese adolescents: a randomized trial. Ann Intern Med (2006) 2.38

Dietary recommendations for children and adolescents: a guide for practitioners. Pediatrics (2006) 2.36

Twenty-four-hour ambulatory blood pressure in children with sleep-disordered breathing. Am J Respir Crit Care Med (2004) 2.34

Relationship between elevated arterial stiffness and increased left ventricular mass in adolescents and young adults. J Pediatr (2011) 2.34

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary. Crit Pathw Cardiol (2005) 2.31

Instability in the diagnosis of metabolic syndrome in adolescents. Circulation (2007) 2.29

Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation (2007) 2.26

Impact of objective and subjective social status on obesity in a biracial cohort of adolescents. Obes Res (2003) 2.24

Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr (2009) 2.21

Dietary recommendations for children and adolescents: a guide for practitioners: consensus statement from the American Heart Association. Circulation (2005) 2.16

Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care (2010) 2.15

A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents. Am J Psychiatry (2006) 2.13

Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: the SEARCH for diabetes in youth study. Diabetes Care (2006) 2.09

Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr (2004) 2.08

Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation (2011) 2.08

Childhood obesity predicts adult metabolic syndrome: the Fels Longitudinal Study. J Pediatr (2007) 2.07

Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth Study. J Pediatr (2006) 2.06

Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans. Diabetes (2010) 2.01

Statistical assessment of mediational effects for logistic mediational models. Stat Med (2004) 1.96

Obesity development during adolescence in a biracial cohort: the NHLBI Growth and Health Study. Pediatrics (2002) 1.92

Systolic blood pressure in childhood predicts hypertension and metabolic syndrome later in life. Pediatrics (2007) 1.88

Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes. J Clin Endocrinol Metab (2012) 1.87

Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease. Proc Natl Acad Sci U S A (2004) 1.86

American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. J Pediatr (2003) 1.85

Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele. Biol Psychiatry (2004) 1.84

Childhood overweight and cardiovascular disease risk factors: the National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr (2007) 1.83

Nontraditional risk factors and biomarkers for cardiovascular disease: mechanistic, research, and clinical considerations for youth: a scientific statement from the American Heart Association. Circulation (2011) 1.81

A1C: does one size fit all? Diabetes Care (2007) 1.79

The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial. Stroke (2008) 1.79

Summary of the Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Hypertension (2004) 1.78

Psychological adjustment of obese youth presenting for weight management treatment. Obes Res (2004) 1.78

Prevalence of dementia in three ethnic groups: the South Florida program on aging and health. Ann Epidemiol (2003) 1.77

Dietary patterns associated with fat and bone mass in young children. Am J Clin Nutr (2010) 1.76

A randomized, placebo-controlled trial of amlodipine in children with hypertension. J Pediatr (2004) 1.75

Influence of race, ethnicity, and culture on childhood obesity: implications for prevention and treatment: a consensus statement of Shaping America's Health and the Obesity Society. Diabetes Care (2008) 1.74

Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets. Diabetes Care (2012) 1.73

Dyslipidemia in youth with diabetes: to treat or not to treat? J Pediatr (2008) 1.72

Adiposity and TV viewing are related to less bone accrual in young children. J Pediatr (2008) 1.71

Socioeconomic differences in adolescent stress: the role of psychological resources. J Adolesc Health (2007) 1.71

The relationship of health outcomes to improvement in BMI in children and adolescents. Obes Res (2005) 1.70

The impact of early nutrition on incidence of allergic manifestations and common respiratory illnesses in children. J Pediatr (2010) 1.70

Trends in the use of psychotropic medications among adolescents, 1994 to 2001. Psychiatr Serv (2006) 1.69

Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: a multisite, single-blind, randomized, controlled clinical trial. Arthritis Rheum (2012) 1.68

Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy. Arch Ophthalmol (2010) 1.68

Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group. Circulation (2005) 1.67

American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 update: a scientific statement for public health practitioners, healthcare providers, and health policy makers. Circulation (2013) 1.66

Prevalence of tobacco use and association between cardiometabolic risk factors and cigarette smoking in youth with type 1 or type 2 diabetes mellitus. J Pediatr (2010) 1.63

Baseline BMI is a strong predictor of nadir BMI after adolescent gastric bypass. J Pediatr (2010) 1.61

Teen-Longitudinal Assessment of Bariatric Surgery: methodological features of the first prospective multicenter study of adolescent bariatric surgery. J Pediatr Surg (2007) 1.61

Increased arterial stiffness is found in adolescents with obesity or obesity-related type 2 diabetes mellitus. J Hypertens (2010) 1.60

Subjective social status in the school and change in adiposity in female adolescents: findings from a prospective cohort study. Arch Pediatr Adolesc Med (2008) 1.60

Sexual orientation and bullying among adolescents in the growing up today study. J Adolesc Health (2010) 1.60

Use of a DASH food group score to predict excess weight gain in adolescent girls in the National Growth and Health Study. Arch Pediatr Adolesc Med (2011) 1.60

Pubertal maturation in girls and the relationship to anthropometric changes: pathways through puberty. J Pediatr (2003) 1.59

Cooperation between brain and islet in glucose homeostasis and diabetes. Nature (2013) 1.59

Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol (2011) 1.58